Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1161135.RA3kc7Nszps_7JxNMBCko5giEjWSajM1go3Hq8C2t_2g0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1161135.RA3kc7Nszps_7JxNMBCko5giEjWSajM1go3Hq8C2t_2g0130_assertion type Assertion NP1161135.RA3kc7Nszps_7JxNMBCko5giEjWSajM1go3Hq8C2t_2g0130_head.
- NP1161135.RA3kc7Nszps_7JxNMBCko5giEjWSajM1go3Hq8C2t_2g0130_assertion description "[ASC amino-acid transporter 2 was expressed in 66% of patients, and was closely correlated with disease stage, lymphatic permeation, vascular invasion, CD98, cell proliferation, angiogenesis, and mTOR phosphorylation, particularly in patients with adenocarcinoma (AC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1161135.RA3kc7Nszps_7JxNMBCko5giEjWSajM1go3Hq8C2t_2g0130_provenance.
- NP1161135.RA3kc7Nszps_7JxNMBCko5giEjWSajM1go3Hq8C2t_2g0130_assertion evidence source_evidence_literature NP1161135.RA3kc7Nszps_7JxNMBCko5giEjWSajM1go3Hq8C2t_2g0130_provenance.
- NP1161135.RA3kc7Nszps_7JxNMBCko5giEjWSajM1go3Hq8C2t_2g0130_assertion SIO_000772 24603303 NP1161135.RA3kc7Nszps_7JxNMBCko5giEjWSajM1go3Hq8C2t_2g0130_provenance.
- NP1161135.RA3kc7Nszps_7JxNMBCko5giEjWSajM1go3Hq8C2t_2g0130_assertion wasDerivedFrom befree-2016 NP1161135.RA3kc7Nszps_7JxNMBCko5giEjWSajM1go3Hq8C2t_2g0130_provenance.
- NP1161135.RA3kc7Nszps_7JxNMBCko5giEjWSajM1go3Hq8C2t_2g0130_assertion wasGeneratedBy ECO_0000203 NP1161135.RA3kc7Nszps_7JxNMBCko5giEjWSajM1go3Hq8C2t_2g0130_provenance.